Cisplatin is known to be what type of toxic agent?

Cisplatin is classified as a nephrotoxic and ototoxic agent due to its mechanism of action and the side effects associated with its use in cancer treatment. As a platinum-based chemotherapeutic drug, cisplatin is effective in targeting and killing rapidly dividing cancer cells. However, it has a propensity to accumulate in the kidneys, leading to nephrotoxicity, which can result in acute kidney injury. This is a significant concern during treatment, and clinicians often monitor renal function closely when administering cisplatin.

Additionally, cisplatin is associated with ototoxicity, which involves damage to the inner ear that can lead to hearing loss or tinnitus. This side effect is particularly relevant for patients undergoing treatment, as it can affect quality of life. Understanding that cisplatin has these dual toxic effects helps in managing patient care and monitoring for complications during chemotherapy.

In contrast, the other types of toxicity mentioned in the options, such as hepatotoxicity (affecting the liver), neurotoxicity (affecting the nervous system), and general cytotoxicity (which refers to the drug's ability to kill cells but does not specifically address organ-specific damage), are not the primary concerns with cisplatin. The recognition of cispl